Matches in Wikidata for { <http://www.wikidata.org/entity/Q65376753> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q65376753 description "clinical trial" @default.
- Q65376753 description "ensayu clínicu" @default.
- Q65376753 description "klinisch onderzoek" @default.
- Q65376753 description "клінічне випробування" @default.
- Q65376753 name "Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery" @default.
- Q65376753 name "Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery" @default.
- Q65376753 type Item @default.
- Q65376753 label "Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery" @default.
- Q65376753 label "Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery" @default.
- Q65376753 prefLabel "Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery" @default.
- Q65376753 prefLabel "Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery" @default.
- Q65376753 P1132 Q65376753-59F56800-1F5D-4973-B8C3-71AD1B967D6D @default.
- Q65376753 P1476 Q65376753-F194C850-ABE0-4316-B383-FA582AB1E9B0 @default.
- Q65376753 P17 Q65376753-0B5F0F4B-22DB-4787-A497-19DB81E0FE15 @default.
- Q65376753 P2899 Q65376753-BD65572A-F793-455D-9FC6-D2FBE80667FC @default.
- Q65376753 P3098 Q65376753-86F6F03E-A333-4E44-AC26-9268E9408817 @default.
- Q65376753 P31 Q65376753-A84FE498-6CC3-41AB-9D95-496A863A37B3 @default.
- Q65376753 P4844 Q65376753-14D0DFFC-50CE-4814-8DC0-2044BC009723 @default.
- Q65376753 P4844 Q65376753-76F21F23-5FBE-460D-9E4B-03898EA995FD @default.
- Q65376753 P580 Q65376753-A3931681-EE5B-414D-8F50-92124C4B3C98 @default.
- Q65376753 P582 Q65376753-21AB023F-26DB-4525-B6EC-C696B19665B6 @default.
- Q65376753 P6099 Q65376753-9DD67FEE-01D5-4574-891F-D901EB3F4C28 @default.
- Q65376753 P6153 Q65376753-45A306A4-0358-4384-A9C7-B8F423C43791 @default.
- Q65376753 P6153 Q65376753-5EE12673-ED41-4DDA-99D5-EE0F5B247C56 @default.
- Q65376753 P6153 Q65376753-A0C9C567-8314-45AA-B019-7212011A206F @default.
- Q65376753 P8363 Q65376753-25C6B2D7-51D5-4CDC-A2C6-0272A37720F2 @default.
- Q65376753 P1132 "+412" @default.
- Q65376753 P1476 "TACE-2: A Randomized Placebo-Controlled, Double Blinded, Phase III Trial of Sorafenib in Combination With Transarterial Chemoembolization in Hepatocellular Cancer" @default.
- Q65376753 P17 Q145 @default.
- Q65376753 P2899 "+18" @default.
- Q65376753 P3098 "NCT01324076" @default.
- Q65376753 P31 Q30612 @default.
- Q65376753 P4844 Q18936 @default.
- Q65376753 P4844 Q29004943 @default.
- Q65376753 P580 "2010-11-01T00:00:00Z" @default.
- Q65376753 P582 "2014-11-01T00:00:00Z" @default.
- Q65376753 P6099 Q42824827 @default.
- Q65376753 P6153 Q4969003 @default.
- Q65376753 P6153 Q7270030 @default.
- Q65376753 P6153 Q7569131 @default.
- Q65376753 P8363 Q78089383 @default.